Sai Life Sciences Limited
Press Release
Sai Life Sciences Limited has reported strong financial results for the first quarter ended June 30, 2026, with revenue up 12% year-on-year and net profit up 22% year-on-year.
28
total announcements
SAILIFE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 16 Oct 2026
Market Cap
₹29,634 Cr
P/E (TTM)
82.4
P/E (Forward)
55.7
EPS (TTM)
₹16.93
52W Low
₹783.85
52W High
₹1,697.00
Dividend Yield
0.00%
Price / Book
11.9
Debt / Equity
11.6
Revenue (TTM)
₹2,250 Cr
Gross Margin
74.46%
Operating Margin
18.41%
Sai Life Sciences Limited
Sai Life Sciences Limited has reported strong financial results for the first quarter ended June 30, 2026, with revenue up 12% year-on-year and net profit up 22% year-on-year.
Sai Life Sciences Limited
Sai Life Sciences Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations at Rs. 5,467.29 million and profit for the period at Rs. 713.39 million.
Sai Life Sciences Limited
Sai Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investors meet to be held on 13 August 2026 & 14 August 2026 at Singapore.
Sai Life Sciences Limited
Sai Life Sciences Limited has informed the Exchange about the schedule of an earnings conference call to discuss the Un Audited Financial Results of the Company for the Quarter ended 30 June 2026.
Sai Life Sciences Limited
Sai Life Sciences Limited has informed the Exchange regarding the allotment of 8,900 shares under the Employees Stock Option Plan 2008 (ESOP 2008).
Sai Life Sciences Limited
Sai Life Sciences Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, regarding the details of securities dematerialized/rematerialized during the period.
Sai Life Sciences Limited
Sai Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Sai Life Sciences Limited
Sai Life Sciences Limited has allotted 170,501 fully paid-up equity shares of Re. 1/- each to employees who exercised options granted under its ESOP 2008 and MESOP 2018 schemes. This allotment, approved on June 22, 2026, increases the total issued shares to 21,22,86,016. The shares were issued at varying exercise prices of Rs. 188.90, Rs. 23.30, and Rs. 127.30, resulting in a minor capital inflow for the company.